Osama Abdelghany, PharmD, MHA, BCOP

home / authors / osama-abdelghany-pharmd-mha-bcop

Articles

Pandemic Management Strategies for Patients With Cancer at an Academic Medical Center

Pandemic Management Strategies for Patients With Cancer at an Academic Medical Center

Martha Stutsky, PharmD, BCPS;Osama Abdelghany, PharmD, MHA, BCOP
September 3rd 2020

At the Smilow Cancer Hospital, oncology pharmacists play an important role in the delivery of care for patients with cancer.

Read More

Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19

Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19

Vinay Sawant, RPh, MPH, MBA;Ayse Hursid, PharmD;Osama Abdelghany, PharmD, MHA, BCOP;Terri Sue Bukowski, PharmD, CSP
July 13th 2020

The COVID-19 pandemic made a convincing argument to employers of having a robust and sound communication strategy to their employees.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD